Metraipolis › archive › dc_cbfd89918a02

Anti-Atherogenic Mechanisms and Therapies — Europe PMC PMID:40833492

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40833492
DOI: 10.1007/s11883-[numero omesso]-9
License (as archived): solo-consultazione
Archived: 2026-11-10T11:31:25.291Z
SHA-256 of the archived text: c8d01771af36e7a67476b090a9804665bf2bec215eb5c3fcddeca6486f898fe8
Stable URL of this page: https://metraipolis.com/documento/dc_cbfd89918a02

How to cite

Anti-Atherogenic Mechanisms and Therapies — Europe PMC PMID:40833492 — Europe PMC (en), https://europepmc.org/article/MED/40833492 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbfd89918a02 (Metraipolis archive dc_cbfd89918a02, sha256 c8d01771af36e7a67476b090a9804665bf2bec215eb5c3fcddeca6486f898fe8)

BibTeX

@misc{dccbfd89918a02,
  title = {Anti-Atherogenic Mechanisms and Therapies — Europe PMC PMID:40833492},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40833492},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbfd89918a02; sha256 c8d01771af36e7a67476b090a9804665bf2bec215eb5c3fcddeca6486f898fe8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40833492. Agents can read the archived copy with the MCP tool read_document.